How blockchain technology can improve the outcomes of clinical trials

Abstract

This article applies ‘outcome-driven innovation’ methodology, developed by Anthony Ulwick and popularised by Clayton Christensen, to the domain of clinical trials. Data were collected through in-depth, open interviews with doctors, nurses and researchers in the UK, France and Italy. Pain points for key players of the value chain were identified. The findings supported a multi-stakeholder approach to fully exploit the transformative potential of blockchain technology to resolve issues. The research identified a set of opportunities for innovators to improve the way hospitals conduct clinical trials using smart contracts and blockchain technology generally.